Status:
UNKNOWN
Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa
Lead Sponsor:
Zealand University Hospital
Conditions:
Hidradenitis Suppurativa
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hidradenitis suppurativa (HS) is a common chronic skin disease where patients experience inflamed painful nodules and chronic suppurating tunnels under the skin that often leave mutilating scars. Symp...
Detailed Description
Background and aim: Hidradenitis suppurativa (HS) is a common chronic skin disease that manifests by intermittent flare-ups of inflamed painful nodules that often leave mutilating scars, chronic supp...
Eligibility Criteria
Inclusion
- Legally competent women and men
- aged 18 years or older
- Two appropriate HS fistulas
Exclusion
- fistulas in areas that have previously received surgery
- Allergy to lidocaine or adrenaline
- Fragile physical health that cannot tolerate standard of care HS rescue therapy
- Pregnant or lactating women
Key Trial Info
Start Date :
December 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04508374
Start Date
December 10 2020
End Date
September 1 2025
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
zealand University Hospital Roskilde
Roskilde, Denmark, 4000